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Last evidences suggest that, in Alzheimer’s disease (AD) early stage, Amyloid-β (Aβ)
peptide induces an imbalance between excitatory and inhibitory neurotransmission
systems resulting in the functional impairment of neural networks. Such alterations
are particularly important in the septohippocampal system where learning and memory
processes take place depending on accurate oscillatory activity tuned at fimbria-CA3
synapse. Here, the acute effects of Aβ on CA3 pyramidal neurons and their synaptic
activation from septal part of the fimbria were studied in rats. A triphasic postsynaptic
response defined by an excitatory potential (EPSP) followed by both early and late
inhibitory potentials (IPSP) was evoked. The EPSP was glutamatergic acting on ionotropic
receptors. The early IPSP was blocked by GABAA antagonists whereas the late IPSP
was removed by GABAB antagonists. Aβ perfusion induced recorded cells to depolarize,
increase their input resistance and decrease the late IPSP. Aβ action mechanism was
localized at postsynaptic level and most likely linked to GABAB-related ion channels
conductance decrease. In addition, it was found that the specific pharmacological
modulation of the GABAB receptor effector, G-protein-coupled inward rectifier potassium
(GirK) channels, mimicked all Aβ effects previously described. Thus, our findings suggest
that Aβ altering GirK channels conductance in CA3 pyramidal neurons might have a key
role in the septohippocampal activity dysfunction observed in AD.
Keywords: septohippocampal system, fimbria-CA3 synapse, amyloid-β25–35 peptide, GABAB, GirK channels,
Alzheimer’s disease, brain slices, intracellular recordings
INTRODUCTION
Being still lack of effective treatments for Alzheimer’s disease
(AD), current research efforts have focused on finding the rela-
tionships between amyloid-β peptide (Aβ) functions and toxic
mechanisms to understand the development of AD (Huang and
Mucke, 2012). Memory deficits and disorientation appear as the
first symptoms of AD (McKhann et al., 1984; Swanberg et al.,
2004) and, among the different regions early affected, damages
found in septum and hippocampus could explain these cog-
nitive deficits (Moreno et al., 2007; Palop et al., 2007; Villette
et al., 2010; Rubio et al., 2012). Both structures are reciprocally
interconnected through fimbria/fornix, and are functionally cou-
pled to form the septohippocampal system (Bland and Colom,
1993), which is critical in generating certain oscillatory activ-
ity, such as theta rhythm, necessary for fundamental processes
in learning and memory (Stewart and Fox, 1990; Bland and
Oddie, 2001; Buzsaki, 2002; Sotty et al., 2003; Colom, 2006;
Colom et al., 2010; Rubio et al., 2012). Theta oscillation coor-
dinates septohippocampal network and depends on intercon-
nections, which include well known cholinergic and GABAergic
(Lynch et al., 1977; Kohler et al., 1984; Bland and Colom, 1993)
as well as glutamatergic (Sotty et al., 2003; Huh et al., 2010)
projections.
In animal models of AD, septohippocampal network dys-
function has extensively been reported (Colom, 2006; Palop and
Mucke, 2010; Peña et al., 2010; Villette et al., 2010, 2012; Rubio
et al., 2012; Verret et al., 2012). At the synaptic level, dysfunction
induced by Aβ on inhibitory neurotransmission causes aberrant
patterns of activity in its associated neural circuits, destabilizes
neuronal networks and impairs oscillatory activity. This scenario,
ultimately, seems to be responsible for the early alteration of the
processes implicated in learning and memory tasks observed in
AD patients (Palop and Mucke, 2010; Huang and Mucke, 2012).
However, the specific mechanisms involving inhibitory neuro-
transmission at the molecular level, synaptic circuits or systems
that consistently explain Aβ neurotoxic effects and associated
neurological deficits remain unknown.
γ-aminobutyric acid (GABA) is the main inhibitory neu-
rotransmitter in the mammalian central nervous system and
is involved in the regulation of many physiological processes.
GABA mediates the inhibitory neurotransmission and accord-
ingly, regulates excitatory activity preventing hyperexcitation,
actions especially relevant to maintain neural network stabil-
ity and oscillatory activity (Palop and Mucke, 2010). GABA
metabotropic type receptors (GABAB) are coupled to intracel-
lular signal transduction mechanisms via G proteins (Mott and
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Lewis, 1994; Kaupmann et al., 1998) and mediate slow and
prolonged synaptic inhibition mainly by postsynaptic G protein-
coupled activated inwardly-rectifying potassium (GirK) channels
(Luscher et al., 1997; Kaupmann et al., 1998). Thus, GirK chan-
nels act as key players in the control of cellular and network
excitability by modulating synaptic activity (Lujan and Ciruela,
2012).
In this study, we aimed to characterize Aβ effects on sep-
tohippocampal fimbria/CA3 synapsis. To address this question,
we used an in vitro preparation taking advantage of the spe-
cific septo-hippocampal projection to CA3 pyramidal neurons,
and evoked a characteristic complex synaptic response in CA3
recorded neurons by stimulating the septal part of the fimbria.
For the first time, we provide evidence that Aβ decreased GABAB
neurotransmission through altering GirK channel conductance.
MATERIALS ANDMETHODS
ANIMALS
Experiments were carried out on male and female rats (80–100 g)
raised in the Salamanca University Animal House (Salamanca,
Spain). All animal procedures were reviewed and approved by
the Ethical Committee for Use of Laboratory Animals of the
University of Salamanca and University of Castilla-La Mancha,
and followed the European Communities Council (86/609/EEC).
PREPARATION OF SLICES
Animals were deeply anesthetized with halothane and decap-
itated. The brain was excised and rapidly immersed in oxy-
genated ice-cold (4–6◦C) artificial cerebrospinal fluid (ACSF),
with sucrose (234mM) replacing the NaCl (117mM) to main-
tain osmolarity. In order to preserve the optimal connectivity
from fimbria fibers on CA3 pyramidal neurons (Gloveli et al.,
2005; Bischofberger et al., 2006), horizontal slices containing
the septal part of the fimbria, i.e., lateral fimbria (Alonso and
Kohler, 1984; Amaral and Lavenex, 2007), and the hippocampus
(350μm-thick) were cut in cold oxygenated Ringer solution using
a vibratome (Leica VT 1000S,Wetzlar, Germany) and placed in an
incubation chamber, where they were maintained for at least 2 h
at room temperature (22◦C) before the recordings. Further details
of this in vitro preparation have been described elsewhere (Yajeya
et al., 2000).
SHARP ELECTRODE RECORDINGS
For recordings, a single septohippocampal slice was transferred to
an interface recording chamber (BSC-HT and BSC-BU; Harvard
Apparatus, Holliston, US) and perfused continuously with ACSF
comprising (in mM) 117 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgCl2, 25
NaHCO3, 1.2 NaH2PO4, and 11 glucose. The ACSF was bubbled
with carbogen gas (95%O2–5%CO2) and maintained at room
temperature during the recordings.
Intracellular sharp electrode recordings from CA3 pyramidal
neurons were obtained with borosilicate glass microelectrodes
(140–180M; WPI, Sarasota, US) filled with a potassium acetate
solution (3M) and connected to the headstage of an intracel-
lular recording amplifier (Bio-logic VF180, Claix, France). Only
data from neurons with both, stable resting membrane potential
(RMP) with values ≤ −60mV in the absence of direct current
(DC) holding currents, and presenting overshooting action
potentials, were collected for analysis. Spike amplitude, afterde-
polarization and afterhyperpolarizing potentials were measured
relative to threshold.
Excitatory and inhibitory postsynaptic potentials (EPSP and
IPSP, respectively) were elicited orthodromically by stimulat-
ing the lateral fimbria where septal afferents to CA3 hip-
pocampal neurons are mainly found (Alonso and Kohler, 1984;
Amaral and Lavenex, 2007). For that purpose a monopo-
lar stainless steel electrode (2M of effective resistance; WPI,
Sarasota, US) and a programmable stimulator (MASTER-8, A8,
A.M.P.I., Jerusalem, Israel) were used. Single, cathodal, square-
wave pulses of 100–200μs duration and 100–500μA intensity
were adjusted to subthreshold values for orthodromic spike gen-
eration. Postsynaptic potentials were characterized according to
their amplitude (as a function of the RMP) and latency. Since
horizontal slices were obtained at different level and angle, some-
times the location of the electrode along lateral fimbria had to be
changed to evoke the characteristic triphasic response.
IDENTIFICATION OF STIMULATION AND RECORDING SITES
Recorded neurons were identified following procedures described
elsewhere (Navarro-Lopez et al., 2004). Briefly, selected neurons
were stained by the intracellular injection of biocytin diluted
in a 2 M potassium acetate solution, using positive current
pulses of 0.2 nA for 6min. Slices were fixed, and cut in sec-
tions (40μm) using a freezing microtome (HM400R, Microm,
Heidelberg, Germany). Sections were incubated with avidin-
biotin-peroxidase complex (ABC, Vector Labs., Burlingame, US).
3,3′-Diaminobenzidine was used as chromogen for visualization
of the biocytin complex. Sections were counterstained with cre-
syl violet. Neuron was reconstructed from serial sections using
a graphic design software. Photographs were superimposed and
orientated to obtain the best fit between the corresponding sec-
tioned elements.
DRUGS
All chemicals used in this study were purchased from
Sigma (Poole, UK) and Tocris (Biogen Científica, Spain)
and applied by superfusion in the ACSF. The chemicals
used were amyloid-β peptides (Aβ25–35 and the reverse
Aβ35–25), 6-cyano-nitroquinoxaline-2,3-dione (CNQX; a potent,
competitive AMPA-kainate receptor antagonist), 2-amino-5-
phosphonovalerate (APV; a specific blocker of NMDA receptors),
Bicuculline Methiodide (specific blocker of GABAA receptors),
(RS)-3-Amino-2-(4-chlorophenyl) propylphosphonic acid
(Saclofen; blocker of GABAB receptors), (RS)-4-Amino-3-
(4-chlorophenyl) butanoic acid (Baclofen; agonist of GABAB
receptors), Tetrodotoxine (TTX; voltage dependent sodium chan-
nel blocker), Tertiapin-Q (selective blocker of GirK channels)
and 2-methyl-2,4-pentanediol (MPD, agonist of GirK channels).
PREPARATION OF Aβ PEPTIDES SOLUTIONS
Aβ25–35 and Aβ35–25 peptides were prepared as previously
(Ashenafi et al., 2005; Santos-Torres et al., 2007). Briefly, the
peptides were dissolved to 1mM in bidistilled water and stored
in aliquots at −20◦C. Then aliquots were diluted in ACSF to
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required concentration and incubated for 24 h at 37◦C before
experiments were performed (Peña et al., 2010; Leao et al., 2012).
DATA STORAGE AND STATISTICAL ANALYSIS
Sharp electrode data were acquired online with the help of a
CED 1401 interface (CED, Cambridge, UK), and stored on a per-
sonal computer (sample frequency 12.5 kHz). Analysis in both
cases was performed using the MiniAnalysis Program, version
6.0.3 (Synaptosoft, Decatur, US). Unless otherwise indicated, the
electrophysiological data are always expressed as mean ± stan-
dard error of the mean (SEM), and n represents the number
of averaged neurons. Synaptic potentials were averaged (≥5)
before quantitative analysis. Statistical analysis of collected data
was performed using either Student’s t-test or non-parametric
test (Mann-Whitney U-test), accordingly with data distribution.
When necessary, one-way ANOVA or equivalent non parametric
test (Kruskal-Wallis test) and post-hoc analysis were performed.
Statistical significance was determined at a level of p ≤ 0.05.
RESULTS
ELECTROPHYSIOLOGICAL CHARACTERIZATION OF RECORDED
NEURONS AND THEIR SYNAPTIC RESPONSE TO FIMBRIA
STIMULATION
This study comprises 110 intracellular recordings from pyrami-
dal CA3 neurons (Figure 1), selected on the basis of their RMP
(≤ −60mV) and monosynaptic activation from the fimbria.
Recorded neurons did not exhibit action potentials spontaneously
at RMP values (−72.5 ± 1.8mV). The input resistance (Ri) of
the neurons was 113.4 ± 6.7M and the membrane time con-
stant was 77.2 ± 25.4ms. The direct activation of these neurons
by depolarizing current injections (0.1–0.6 nA ; 300ms) evoked a
series of two to five spikes with marked spike frequency adapta-
tion and decreased amplitude and longer duration of the second
spike relative to the first one (Figure 1B). The spike amplitude
was 101.1 ± 3.2mV. These characteristics, together with neu-
ronal morphology (Figure 1D) and other electrophysiological
properties such as the presence of triphasic afterhyperpolariza-
tion (fAHP: 5.6 ± 0.8mV; mAHP: 10.5 ± 1.5mV; sAHP: 17.6 ±
1.3mV) or afterdepolarization (ADP: 3.6 ± 0.5mV), characterize
the principal pyramidal-like neurons widely described in the hip-
pocampus (Spruston and Johnston, 1992; Wittner et al., 2007).
The location of selected neurons (n = 10) filled with biocytin is
illustrated in Figure 1A. The morphology corresponds to pyrami-
dal neurons in CA3 region of the hippocampus. The cell body is
located into the stratum pyramidale and the visible basal dendrites
on stratum oriens (Figure 1D).
Single subthreshold stimulation of the fimbria evoked stereo-
typed triphasic synaptic responses in CA3 pyramidal cells
(Figure 2). The initial response was a fast EPSP, which occurred at
a latency of 6.5 ± 0.6ms following stimulus offset, suggesting the
monosynaptic nature of the connection. The size of the EPSP was
graded with the stimulus intensity and it increased in amplitude
when elicited at progressively more negative membrane poten-
tials (Figure 2A). The EPSP was followed by a rapidly developing
hyperpolarization (early IPSP, Figures 2A,B) that reached its peak
amplitude 30.4 ± 1.4ms (n = 11) following fimbria stimula-
tion. Finally a second hyperpolarization (late IPSP, Figures 2A,B)
FIGURE 1 | Location and electrophysiological characterization of the
recorded neurons in hippocampal slices. (A) Experimental design.
Diagram of stimulation and recording sites in an hippocampal horizontal
section. Schematic location of recording (Rec.) and stimulating (St.)
electrodes is shown. Stimuli were applied to the lateral part of the fimbria
(shaded area). (B) Response of a CA3 neuron to depolarizing pulses
consisted of two to five spikes with marked spike frequency adaptation
with a depolarizing current pulse (100 pA, 300ms) while hyperpolarizing
current pulse injection (−160 pA, 300ms) induced a hyperpolarizing
response that allowed us monitoring the input resistance during the
experiments. (C) Current-voltage (I-V ) relationships for the pyramidal
neuron recorded in (B). (D) Reconstruction of the CA3 neuron recorded in
(B,C) labeled with biocytin after intracellular recording from 40-μm-thick
serial sections. Note the pyramidal morphology of the injected hippocampal
cell. ori, stratum oriens; pyr, stratum pyramidale; luc, stratum lucidum;
Scale bar 50μm.
following the early IPSP, had a latency to peak amplitude of
247.4 ± 6.6ms (n = 44). The amplitudes of both, IPSPs and
EPSP, varied with membrane potential (Figures 2A,B), allow-
ing us to determine the approximate reversal potential for both
inhibitory components (early −61.1mV and late −80.0mV).
In order to determine the nature of the complex response,
a pharmacological dissection of the postsynaptic potential com-
ponents was performed (Figure 3). The early IPSP was blocked
by bicuculline (10μM, n = 6), a specific blocker of GABAA
receptors (Figures 3A,C–E) whereas late IPSP was removed by
saclofen (200μM; n = 5), a specific blocker of GABAB recep-
tors (Figures 3B,E). The excitatory component was increased
by early IPSP block with bicuculline (n = 9; Figures 3A,C–E)
and presented a glutamatergic nature acting mainly on non-
NMDA (n = 5; Figure 3D) receptors, since although its com-
plete elimination required CNQX (10μM) and APV (50μM)
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FIGURE 2 | Postsynaptic septohippocampal response in CA3 pyramidal
neurons. (A) Effect of membrane potential variations on the amplitude of
the early and late IPSPs evoked by orthodromic activation in a pyramidal
CA3 neuron. Stimulation of the fimbria elicited an EPSP followed by an
early (open circles) and late (closed circles) IPSP. Traces shown are the
average of five responses. (B) Effect of varying the intensity of fimbria
stimulation on the complex postsynaptic response recorded in another
neuron at a membrane potential of −60mV. From top to bottom, traces
represent synaptic responses which were evoked by progressive
increments in fimbria stimulation. Stimulation of the fimbria at a low
intensity evoked only EPSP followed by an early (◦, open circles) IPSP.
Delivery of stimulation at higher intensities resulted in the elicitation of a
subsequent late (•, closed circles) IPSP. The approximate reversal potential
for both inhibitory components was early −61.1mV and late −80.0mV.
the cells were held at −75mV (a membrane potential where
NMDA receptor-mediated currents are null). However, when
recorded cells were held at more positive values than RMP
(n = 4; Figure 3C), NMDA channels were entirely functional
and perfusion with APV decreased both bicuculline-enhanced
responses, EPSP and late IPSP (Figure 3E), suggesting the par-
ticipation of NMDA receptors in the response. As previously,
complete blockage of EPSP also required CNQX (Figure 3C).
In this regard, the pharmacological elimination of glutamater-
gic responses with CNQX plus APV also abolished the inhibitory
response (Figures 3C,D) suggesting that IPSPs were produced by
interneurons activation.
On the other hand, when both inhibitory components
were removed an epileptiform-like discharge was generated
(Figures 3F,G). This response could reach a firing frequency
of 90Hz and showed a glutamatergic nature acting mainly
on non-NMDA receptors, since CNQX completely abolished
it (Figure 3F) whereas APV only could block it partially
(Figure 3G).
These results indicate that the triphasic complex response
involves excitatory and inhibitory neurotransmission mediated
by glutamate and GABA receptors activation, suggesting that
a precise tuning is required for information processing at this
synapse.
Aβ25–35 DIFFERENTIAL EFFECTS ON MEMBRANE PROPERTIES
In all cases, the recordings were stabilized for at least 10min.
During this time, characterization of firing pattern, membrane
potential, Ri and synaptic responses were performed. The speci-
ficity of the Aβ25–35 peptide action was confirmed by the use,
as negative control, of the reverse sequence Aβ35–25 (1.5μM),
without any noticeable effect (Figures 4A,C). Then, slices were
perfused with increasing concentrations of Aβ25–35 (0.5, 1.0, and
1.5μM) for at least another 10min at each concentration.
No significant differences were found in spike ampli-
tude [F(3, 50) = 2.62, p = 0.062], threshold [F(3, 50) = 2.14, p =
0.108], ADP [F(3, 22) = 0.576, p = 0.638], fAHP [F(3, 31) = 1.22,
p = 0.320], or sAHP [F(3, 33) = 1.625, p = 0.204] after perfu-
sion with Aβ25–35 at increasing concentrations. However, as
shown in Figures 4B,C, a significant depolarization was observed
when Aβ25–35 was applied (1μM; 4.3 ± 2.3mV; n = 4; and
1.5μM; 6.2 ± 1.6mV; n = 10). The membrane potential of
the recorded neurons was maintained at its RMP value by
DC holding current injection to cancel out the depolarization
induced by Aβ25–35 (Figure 4D). These variations in current
injection were statistically significant at 1.0μM (t = 2.557, p =
0.021) and 1.5μM (t = 4.301, p < 0.001) concentrations and
no difference was observed at 0.5μM concentrations (t = 0.842,
p = 0.412). Additionally, Aβ25–35 also produced a significant
increase in the relative Ri (% = Ri recorded/Ri control ∗100;
n = 16) (Figures 4D–F) at 1.0μM concentration (t = −2.635,
p = 0.018) and 1.5μM (t = −3.236, p = 0.007) whereas no dif-
ferences were found at 0.5μM (Mann–Whitney U Statistic =
10.000, p = 0.690) (Figures 4E,F).
To determine the synaptic location of these Aβ25–35 effects,
slices were perfused with TTX and any afferent synaptic activ-
ity was blocked. In these conditions, superfusion of the slice
with Aβ25–35 was able to evoke both, depolarization and Ri
increasing (Figure 4D) of intracellularly recorded CA3 pyrami-
dal neurons, suggesting a postsynaptic location for the Aβ25–35
action mechanism (n = 5).
DIFFERENTIAL EFFECTS OF Aβ25–35 ON FIMBRIA-CA3 SYNAPTIC
RESPONSE
Since Aβ has widely shown to exert its effects through sep-
tohippocampal network impairing, we examined whether this
peptide altered the fimbria-CA3 complex postsynaptic response
(n = 20). In the experiment shown in Figure 5A, superfusion of
Aβ25–35 produced a significant decrease of the late IPSP compo-
nent (1μM; t = 2.532, p = 0.030 and 1.5μM; t = 2.519, p =
0.036) that was neither observed at 0.5μM (t = 1.133, p =
0.295) nor on early IPSP (H = 2.578; p = 0.461). However, the
late IPSP reduction was associated with an increase in the excita-
tory response observed at concentration of 1.5μM (t = −2.503,
p = 0.046) but not at lower concentrations (Figures 5B,C). These
results indicate a possible mechanism to imbalance the particular
excitatory/inhibitory tuning in the septohippocampal system, and
therefore a differential Aβ25–35 effect, according to the specific
neurotransmission system involved.
Due to this differential Aβ25–35 effect on both inhibitory com-
ponents, the late component reduction may not be attributable
to a decreased neurotransmitter release since GABAA component
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FIGURE 3 | Pharmacological characterization of septohippocampal
synaptic response. (A) Recordings from a pyramidal CA3 neuron
illustrating a marked reduction of the early IPSP after perfusion with
bicuculline (10μM; specific blocker of GABAA receptors). (B) Blocking of
the late IPSP after perfusion with saclofen (200μM; blocker of GABAB
receptor) was accompanied by a mild increase of the early IPSP and EPSP.
(C) The increase in the amplitude of EPSP and late IPSP produced by
perfusion of bicuculline was reduced by APV application (50μM; specific
blocker of NMDA receptor). Membrane potential was maintained at values
more positives than resting membrane potential to assure NMDA
receptors functionality. Synaptic response was completely removed with
the addition of CNQX (10μM; competitive non-NMDA receptor antagonist).
(D) Blockade of the early IPSP with bicuculline (n = 4) was associated with
a marked increase in amplitude of EPSP and late IPSP. Excitatory and
inhibitory responses were blocked by CNQX and APV. The cells were held
at −75mV (a membrane potential where NMDA receptor-mediated currents
are null). (E) Histograms with relative mean amplitude as percentage of
control of the different components of the complex synaptic response
(EPSP; early, e.IPSP; and late, l.IPSP) under pharmacological conditions
described in (A–D) (∗∗p < 0.001). (F) Both, early and late IPSPs were
blocked by bicuculline and saclofen, respectively, while a large repetitive
burst of action potential appeared (n = 4). At membrane potential values
that assured NMDA activation, this epileptic-like activity could be removed
by CNQX. Finally, residual excitatory NMDA response was eliminated by
APV perfusion. (G) During the epileptic-like activity induced by both
inhibitory components elimination, and at membrane potential values that
led NMDA receptor activation, APV perfusion reduced the size of the
epileptic response that had to be removed by addition of CNQX (n = 4).
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FIGURE 4 | Effects of Aβ25–35 on membrane potential and Ri of
CA3 neurons. (A) Recording of a CA3 pyramidal neuron during the
perfusion of the reverse sequence of the peptide, Aβ35–25, used as
negative control (n = 4). (B) Depolarization of membrane potential
induced by perfusion of Aβ in a recorded pyramidal CA3 neuron
(n = 10). (C) Plot of the membrane potential variations as a
percentage of resting membrane potential (RMP). Perfusion of Aβ35–25
1μM or Aβ25–35 0.5μM did not induce any significant change in the
membrane potential or Ri. Aβ25–35 higher concentrations induced the
cells to depolarize (1μM; 6.8 ± 3.2 %, n = 4; 1.5μM, 8.6 ± 2.2 %,
n = 10). (D1) Time course of Aβ effects on Ri in a CA3 pyramidal
neuron after perfusion with TTX. The membrane potential was held at
its RMP value by direct current (DC) holding current injection to
cancel out the depolarization. (D2) For the same neuron, each point
represents the Ri during the recording in (D1). Membrane potential
was held at −71mV. (E) Plot showing the time course of the effects
of Aβ25–35 concentration increase on the Ri of a CA3 pyramidal
neuron. Note that recordings last for a very long time. (F) Histogram
with mean values in percentage for Ri (n = 10) at different Aβ25–35
concentration (∗p < 0.05).
amplitude was maintained. This result pointed out to a selective
postsynaptic action on GABAB complex.
Aβ25–35 EFFECTS CAN BE EXPLAINED BY A REDUCTION IN THE
CONDUCTANCE OF GirK CHANNELS COUPLED TO GABAB RECEPTOR
Depolarization caused by Aβ25–35 was associated to Ri increase
and therefore, linked to a possible decrease in membrane con-
ductance, which may very likely involve in ion channels closing.
Given the correlation between reduction in GABAB component
and Ri increase shown in Figure 5D, we investigated whether
these Aβ25–35 effects could bemediated by conductance reduction
of GABAB effector, GirK channel. We found that GirK block-
ade by its selective antagonist, tertiapin-Q (0.5μM), not only
removed the GABAB component (late IPSP; Figures 6A,B) of
the synaptic response, but also induced a significant increase in
Ri (Figures 6C,D; 122.5 ± 5.4%; t = −3.264; p = 0.022) as well
as membrane depolarization (Figure 6E; 9.1 ± 2.6mV; n = 5;
t = 8.69, p < 0.001), therefore mimicking all Aβ25–35 effects
previously described.
To determine the mechanism involved in the postsynaptic
reduction of the late IPSP amplitude and Ri increase, pharma-
cological blockage of different receptors/channels was performed
and effects of increasing Aβ25–35 concentrations on Ri were eval-
uated (Figure 7). The blockade of synaptic transmission by TTX
did not produce significant changes in Ri (Mann-Whitney U,
p = 0.700) compared to control (Figures 7A–C, Exp. 1–3). Then,
Aβ25–35 perfusion produced a significant increase in Ri (n = 4)
at high concentrations (Figure 7, Exp. 1; 1.0μM, t = −7.424;
p = 0.018 and 1.5μM, t = −7.519; p = 0.002), which was not
observed at 0.5μM (Mann-Whitney U, p = 1.00). These results
indicate a postsynaptic Aβ25–35 mechanism that quite likely
involves a reduction in ion channels conductance.
On the other hand, since saclofen perfusion prevented
Aβ25–35-induced changes on Ri (n = 6; H = 3.964, p = 0.411;
Figure 7, Exp. 2), an interaction with GABAB receptors might
be assumed. However, although saclofen also induced a reduc-
tion on late IPSP amplitude (see Figures 3B,E), in the presence of
TTX it did not exhibit any noticeable effect on membrane poten-
tial (1.7 ± 2.8mV; t = −0.541; p = 0.617; non illustrated) or Ri
(Figure 7, Exp. 2; 94.5 ± 7.3%; t = 1.198; p = 0.285), in contrast
to Aβ25–35. Altogether, these results suggest that Aβ25–35 exerts
its effects acting preferentially on postsynaptic GirK channels,
instead of GABAB receptors.
In accordance with this hypothesis, Aβ25–35 was found to be
unable to generate additional increase on Ri after postsynap-
tic blockage of GirK channels by tertiapin-Q [Figure 7, Exp. 3;
n = 6; F(3, 21) = 0.129, p = 0.941], suggesting that Aβ-induced
Ri increase may be associated to a reduction in GirK channel con-
ductance. However, because conductance depends, among others,
on the number of channels, their open probability or membrane
voltage, the methodology used in the present study has some
limitations to determine the exact mechanism for Aβ-mediated
Ri increase. In addition, in some experiments, it was necessary
to inject DC to maintain a stable membrane potential and to
prevent depolarization. Previous studies had reported that depo-
larization mechanisms induced by Aβ might involve activation of
glutamatergic receptors (Blanchard et al., 2002a,b). In order to
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FIGURE 5 | Selective effect of Aβ25–35 on different components of
the complex postsynaptic response recorded in CA3 pyramidal
neurons by fimbria stimulation. (A) Evoked responses obtained in a
pyramidal CA3 neuron by fimbria orthodromic stimulation (control) and
during perfusion of different concentrations of Aβ25–35 (0.5, 1, and
1.5μM). The reduction of the late IPSP after perfusion with Aβ25–35
has been shown to be concentration-dependent. (B) Plot displaying the
time course of Aβ25–35 perfusion effects on the amplitude (inmV) of
the different components of the complex response (EPSP, black
diamonds; early IPSP, gray squares; late IPSP, white triangles; see color
code in C). (C) Histograms with relative mean amplitude (n = 20) of the
different components of the complex synaptic response (EPSP; early,
e.IPSP; and late, l.IPSP) 10min after Aβ25–35 perfusion (0.5, 1, and
1.5μM). Significant differences were found for EPSP at 1.5μM Aβ25–35
and for late IPSP at 1–1.5μM Aβ25–35. (D) Correlation analysis of
Aβ25–35 perfusion on different components of the complex postsynaptic
response vs. Ri values. Data showed a higher correlation between
Aβ-induced Ri increase and late IPSP amplitude (R = −0.73, p < 0.001;
D3) than Aβ-induced Ri increase and EPSP (R = 0.42, p < 0.001; D1) or
early IPSP (R = 0.31, p < 0.01; D2)(∗p < 0.05; ∗∗p < 0.01).
control these variables, tertiapin-Q was perfused together with
glutamatergic antagonists CNQX (10μM) and APV (50μM).
This protocol not only prevented the Aβ-mediated increase in
Ri, but also abolished the dependence of DC injection to com-
pensate membrane depolarization (n = 4; H = 3.709, p = 0.447;
non illustrated). In contrast, perfusion with CNQX, APV and the
GABAA blocker, bicuculline (10μM), was not able to prevent the
Ri increase induced by Aβ25–35 (n = 4; H = 21.681; p < 0.001;
non illustrated) further suggesting an effect of Aβ25–35 on GirK
channels.
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FIGURE 6 | Effects of the selective GirK channel antagonist tertiapin-Q
on CA3 pyramidal neurons complex response to fimbria stimulation.
(A) Selective blockade by tertiapin-Q of the late IPSP recorded in CA3
pyramidal neurons after fimbria stimulation. Superfusion of the GirK
antagonist tertiapin-Q (0.5μM; selective blocker of GirK channels)
selectively blocked the late IPSP but did not reduce the early IPSP that was
elicited by fimbria stimulation. (B) Histograms with relative mean amplitude
(n = 5) of the different components of the complex synaptic response
(EPSP; early, e.IPSP; and late, l.IPSP) 40min after tertiapin-Q perfusion.
Significant differences were found for late IPSP. (C) Results of an
experiment in another neuron designed to assess the postsynaptic effects
of tertiapin-Q on Ri of CA3 pyramidal neurons. Perfusion of TTX (n = 5;
1μM; voltage-dependent sodium channel blocker) blocked afferent
neurotransmission and therefore any effect of tertiapin-Q took place at
postsynaptic location. Note the significant Ri increase after 30min. (D)
Histogram with mean values in percentage for Ri (n = 6) after tertiapin-Q
perfusion during 40min (∗p < 0.05). (E) Effect of tertiapin-Q on CA3
pyramidal neurons membrane potential (n = 5). Chart record shows that
superfusion of tertiapin-Q (0.5μM) produced a marked depolarization when
applied at resting membrane potential (−65mV). ∗∗p < 0.01.
EFFECTS OF Aβ25–35 ON THE HYPERPOLARIZATION MEDIATED BY
GABAB-GirK ACTIVATION
Given that, Ri changes may depend on multiple factors and
might be affected by Aβ acting on different ion channels and
receptors, we designed a protocol to specifically evaluate the
effects of Aβ25–35 on GABAB response. To verify whether Aβ25–35
affects the postsynaptic response mediated by GABAB recep-
tor activation, we used a drug cocktail including: TTX to block
synaptic transmission, bicuculline to block GABAA receptors acti-
vation and baclofen to stimulate GABAB receptors (Figure 8).
Cocktail application in the slice produced a postsynaptic mem-
brane hyperpolarization in recorded CA3 pyramidal neurons
(Figures 8A,D; −9.5 ± 2.8% of the RMP value). When mem-
brane potential was stabilized, Aβ25–35 perfusion induced a pro-
nounced depolarization (Figures 8A,D; 15.5 ± 4.3 % of the RMP
value; n = 4), which confirms that Aβ25–35 reduces the postsy-
naptic GABAB response in a concentration and time dependent
manner. But Aβ25–35 action on this GABAB response might also
be explained by an effect on its final effector, GirK, which would
also underlie the already described Aβ25–35 effects on Ri and
membrane depolarization.
In order to validate this hypothesis and evaluate the effect
of Aβ25–35 on GirK response, we used a GirK channel ago-
nist, MPD (Aryal et al., 2009). Bath application of the previ-
ous drugs cocktail together with MPD (50mM) induced the
cell to hyperpolarize by two postsynaptic mechanisms, GABAB
receptor activation and direct increase in GirK conductance
(Figure 9;−11.2 ± 3.8%of the RMP value; n = 15). Then, perfu-
sion of Aβ25–35 (1–1.5μM) removed the hyperpolarizationmedi-
ated by GABAB-GirK stimulation (Figures 9A,E; 5.9 ± 2.7%;
n = 3, Figures 9B,E; 4.2 ± 2.4%, n = 4), while this effect was
not evident at 0.5μM (Figures 9C,E; −7.2 ± 4.8% n = 4). In
fact, the hyperpolarization could be eliminated when the cocktail
was washed (Figure 9C). Finally, Aβ-induced depolarization was
mimicked by tertiapin-Q, the specific antagonist of GirK chan-
nels (Figures 9D,E; 5.5 ± 1.5%; n = 4), indicating that Aβ25–35
directly affects GirK channels conductance.
DISCUSSION
Despite the importance that rhythms as an emergent property of
neural network seem to have, few studies have investigated how
Aβ induces injury and how it may contribute to impair septo-
hippocampal oscillatory activity, which in turn may underlie the
early symptoms typically observed in AD patients (Colom, 2006;
Palop and Mucke, 2010; Villette et al., 2010; Rubio et al., 2012;
Verret et al., 2012). The present study identifies alterations in
GirK channels conductance of fimbria-CA3 synapse as a putative
mechanism of Aβ-induced synaptic dysfunction observed in the
septohippocampal system activity.
SEPTOHIPPOCAMPAL SYSTEM AND Aβ25–35 NEUROTOXICITY
Previously, it has been proposed that Aβ25–35 constitutes the bio-
logically active fragment of Aβ (Millucci et al., 2010), and has
been shown to induce major neuropathological signs related to
early stages of AD in rats (Klementiev et al., 2007). In addition,
Aβ25–35 is reported to be more soluble and presents toxic effects
more rapidly than the parent peptide Aβ1–42 (Varadarajan et al.,
2001), and has widely been used as a very useful tool to explore
acutely the pathophysiological events related with neuronal dys-
function induced by soluble Aβ forms (Ashenafi et al., 2005;
Santos-Torres et al., 2007; Peña et al., 2010; Leao et al., 2012). But
the most important advantage for present work is that Aβ25–35
does not form ion-permeable pores in neuronal membrane (Jang
et al., 2010; Chang et al., 2011; Leao et al., 2012) which could alter
our protocols, especially input resistance measurements.
From neuroanatomical and electrophysiological points of
view, hippocampus receives different projections from the medial
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FIGURE 7 | Histograms with Ri mean values in CA3 pyramidal neurons
for increasing Aβ25–35 concentrations. (A) Normalized mean value of Ri as
% of control after perfusion with three different Aβ25–35 concentrations in
three different experimental conditions (Exp. 1–3). In all cases, TTX
pre-treatment (1μM; voltage-dependent sodium channel blocker) was unable
to prevent Aβ25–35 effects on Ri, suggesting a postsynaptic location for
Aβ25–35 action. Exp. 1: Significant increase on Ri was recorded after 1 and
1.5μM Aβ25–35 perfusion (n = 16), even in the presence of TTX. Exp. 2: After
perfusion of both TTX and saclofen (to block postsynaptic GABAB receptors),
Aβ25–35 was unable to evoke any significant modification in Ri (n = 6). Exp. 3:
As in the experiment showed in Figure 6B, TTX perfusion together with the
selective antagonist of GirK channels, tertiapin-Q (0.5μM), induced a
significant increase in Ri compared to control values. However, when
tertiapin-Q was perfused and GirK channels blocked, Aβ25–35 became unable
to induce any additional Ri increase (n = 6). Control value for Ri was
normalized to 100%. Data show mean ± SEM. ∗p < 0.05. Lower-case letters
(a–e) indicate the five pharmacological conditions during each experimental
treatment. (B) Representative examples for time course of Ri recorded in
experimental conditions (Exp. 1–3). The arrows indicate the time point at
which drugs were applied during the recordings. (C) Representative examples
of recordings were expanded in time to show the changes in membrane
potential during the presentation of hyperpolarizing pulses. This protocol
allowed us to monitor Ri during the whole recording and to study the effect of
different pharmacological treatments represented by lower-case letters (a–e).
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FIGURE 8 | Effects of Aβ25–35 on postsynaptic hyperpolarization induced
by activation of GABAB receptors. (A) Membrane potential recording from
a CA3 neuron (top) after perfusion with TTX (1μM; voltage-dependent sodium
channels blocker), bicuculline (10μM; specific blocker of GABAA receptor)
and baclofen (15μM; agonist of GABAB receptor). This treatment (n = 4)
produced a membrane hyperpolarization depending on GABAB postsynaptic
receptors activation. Perfusion with Aβ25–35 (1 and 1.5μM) markedly induced
the membrane to depolarize. (B) Intracellular hyperpolarizing current pulses.
The arrows indicate the time points at which recordings were expanded in
time to show the changes in the membrane potential during the presentation
of hyperpolarizing pulses. This protocol allowed us to monitor Ri during the
whole recording and check the viability of the neurons. Dashed lines in (A)
and (B) indicate membrane resting potential. Maximum membrane potential
evoked by Aβ25–35 superfusion is indicated by dotted lines. (C) In the same
neuron, fimbria stimulation elicited the characteristic triphasic postsynaptic
response before drugs cocktail perfusion. This complex postsynaptic
potential was completely removed by TTX (1μM; voltage-dependent sodium
channels blocker) perfusion. (D) Plot of the membrane potential variations as
a percentage of resting membrane potential (RMP) under pharmacological
conditions presented in (A). TTX, bicuculline and baclofen (drug cocktail)
induced pyramidal neurons to hyperpolarize while Aβ25–35 produced a
noticeable depolarization (n = 4; 21.4 ± 5.9mV). ∗p < 0.05.
septum diagonal broca bandmainly through lateral fimbria (Wyss
et al., 1980; Alonso and Kohler, 1984; Colom, 2006; Amaral and
Lavenex, 2007). Cholinergic neurons innervate pyramidal neu-
rons and interneurons (Widmer et al., 2006), GABAergic fibers
project onto interneurons (Freund and Antal, 1988; Chamberland
et al., 2010) and glutamatergic projections contact with CA3 pyra-
midal cells (Huh et al., 2010). These septo-hippocampal circuits
are involved in both, generating hippocampal theta rhythm, as
well as in learning and memory processes. To maintain these
high-level functions, a precise septohippocampal network activity
requires of finely regulated excitatory and inhibitory neurotrans-
mission (Buzsaki, 2002; Sotty et al., 2003; Borhegyi et al., 2004;
Colom, 2006) whose alteration could lead to impairments that
would be consistent with the deficits described for AD initial
stages (Bland and Colom, 1993; Palop and Mucke, 2010). In
this sense, it has been reported that in hippocampus, Aβ mainly
induces aberrant inhibitory septohippocampal network activity
(Palop et al., 2007; Villette et al., 2010, 2012). Therefore, although
an Aβ effect on inhibitory neurotransmission might be expected,
the putative mechanism to detune the network coordination of
this system remains unclear.
Aβ25–35 was found not to affect the active properties of CA3
pyramidal recorded neurons suggesting that Aβ25–35 does not
modify the conductances that mediate active membrane prop-
erties such as sodium or potassium voltage-gated channels for
spike amplitude (Hille, 2001), BK/SK channels for AHPs (Sah
and Faber, 2002) or R-type calcium channels for ADP (Metz
et al., 2005). Similar results have also been shown in other
AD related regions as amygdala (Ashenafi et al., 2005), septum
(Santos-Torres et al., 2007), or cortex (Wang et al., 2009).
On the other hand, Aβ25–35 induced an Ri increase associ-
ated with membrane depolarization. We have previously showed
that Aβ25–35 exerts variable effects on membrane potential and
Ri in amygdalar pyramidal neurons, possibly due to a presynaptic
mechanism (Ashenafi et al., 2005) and in septal neurons, depend-
ing on pre- and postsynaptic actions (Santos-Torres et al., 2007).
In the present study, TTX was not able to prevent Aβ25–35 effects
suggesting a direct effect of Aβ25–35 on CA3 pyramidal neurons
membrane.
Previous research has shown that neurotransmission in the
septohippocampal system is affected by Aβ through altering the
theta oscillatory activity (Colom et al., 2010; Rubio et al., 2012),
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FIGURE 9 | Effects of Aβ25–35 perfusion on the response evoked by
pharmacological co-activation of GirK channels and GABAB receptors.
(A,B) GirK/GABAB postsynaptic hyperpolarization was induced (n = 15) by
perfusion of drugs cocktail including TTX (1μM; voltage-dependent sodium
channels blocker), bicuculline (10μM; specific blocker of GABAA receptors),
baclofen (15μM; agonist of GABAB receptors), and MPD (50mM; GirK
channel agonist) perfusion. Aβ25–35 1.5μM (n = 3) and 1.0μM (n = 4)(A
and B, respectively) evoked a postsynaptic depolarization. (C) Using the
same protocol, Aβ25–35 0.5μM was not able to produce this depolarization.
The cocktail hyperpolarizing effect on membrane potential disappeared after
cell washing with bathing solution (n = 4). (D) Tertiapin-Q (n = 4; 0.5μM;
selective blocker of GirK channels), the specific antagonist of GirK channels,
induced a depolarization of the postsynaptic hyperpolarization mediated by
GirK/GABAB activation, reproducing Aβ25–35 effects. (E) Plot showing the
membrane potential changes as a percentage of resting membrane
potential (RMP) under pharmacological conditions presented in (A–D).
∗p < 0.05.
but studies at the synaptic level on the mechanisms underly-
ing this alteration have not been exhaustively performed. Thus,
the possibility of studying in a single preparation and in a
particular synapse, excitatory and inhibitory neurotransmission,
presents fimbria-CA3 synapse preparation as an excellent model
for dissecting the possible mechanisms involved in Aβ action on
different septohippocampal neurotransmission systems.
A biphasic (glutamatergic, non-NMDA, and GABAergic,
GABAA) response in CA3 region after fimbria stimulation
(Schneiderman et al., 1992) has previously been reported.
However, we found a complex synaptic response comprising three
phases: an ionotropic glutamatergic EPSP (Huh et al., 2010) fol-
lowed by two IPSPs, early (GABAA), and late (GABAB). This
complex response has also been described in pyramidal neu-
rons of basolateral amygdaloid nucleus (Washburn and Moises,
1992a), in CA3 pyramidal cells after hilus and mossy fibers
stimulation (Malouf et al., 1990; Scanziani et al., 1991). In our
study, the inhibitory feedback seems to be mediated by acti-
vation of GABAergic interneurons and depends on glutamater-
gic activation, since the block of EPSP also eliminated both
IPSPs. The loss of GABAA inhibition led to an increase in EPSP
and late IPSP amplitudes whereas complete GABAergic compo-
nent block induced an epileptic-like response mainly mediated
by non-NMDA receptors, although NMDA antagonist reduced
the response partially. Very similar results have been shown
in neurons from CA3 hippocampal region (Scanziani et al.,
1991) or frontal cortex (Sutor and Luhmann, 1998) possibly
caused by an increased excitation of interneurons arising from
disinhibited excitatory neurons, and disinhibition of interneu-
rons due to block of GABAA receptors on the inhibitory cell.
This machinery has been suggested as a self-protective mecha-
nism for the control of recurrent activity when an imbalance of
the system occurs (Scanziani et al., 1991; Sutor and Luhmann,
1998).
On the other hand, although it has been reported that cholin-
ergic septal neurons innervate pyramidal CA3 neurons and
interneurons (Widmer et al., 2006), it is also known that cholin-
ergic axons must be activated by train stimulation (>30Hz)
(Washburn and Moises, 1992b; Faber and Sah, 2002; Navarro-
Lopez et al., 2004). It can therefore be suggested that cholinergic
axons projecting onto CA3 neurons were not activated during
single stimulation of the fimbria.
Aβ25–35 EFFECTS ON THE COMPLEX FIMBRIA-CA3 SYNAPTIC
RESPONSE
In the present study, pharmacological characterization of the
complex septohippocampal synaptic response revealed the glu-
tamatergic nature of the EPSP. Glutamatergic septohippocampal
neurons (Colom et al., 2005; Huh et al., 2010) have shown spon-
taneous firing at theta frequencies and Aβ increases this frequency
(Leao et al., 2012), suggesting Aβ to be likely to impair septohip-
pocampal excitatory and network activity through more than one
mechanism.
We found Aβ25–35 to increase the EPSP. This result may
be explained because excitatory response is strongly braked by
the GABAB activity (Otmakhova and Lisman, 2004; Chen and
Johnston, 2005), and Aβ25–35 diminished late IPSP. Since late
IPSP was generated by GABAB receptors stimulation, an Aβ25–35
effect on such receptors, on its intracellular signaling mechanism,
or on its final effector, GirK channels, could be hypothesized.
Assuming that the early GABAA component is not affected by
Aβ25–35, the reduction of GABAB component would not be due to
an inhibition of GABA release or other presynaptic mechanism.
Together with Ri increase and membrane depolarization, our
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results lead to a reduction of the conductance of potassium
channels coupled to GABAB receptor.
Binding studies in postmortem AD patients have shown
a reduction in GABA receptors density in the hippocampus
(Chu et al., 1987). More recently, the 17A polymerase has been
described to be responsible for generating alternative splicing of
GABAB2 subunit in AD patients (Massone et al., 2011). This mod-
ification affects intracellular signaling pathway and activation of
GirK channels, and is also associated with an increased secretion
of Aβ, suggesting a relationship between the metabolism of APP
protein and dysfunction in the GABAB receptor signaling.
Aβ25–35 ACTION ON GirK CHANNELS
When fimbria is stimulated, GABAergic interneurons activate
GABAB receptors of CA3 pyramidal cells; Aβ25–35 behaves as a
selective antagonist and reduces late IPSP. However, the GABAB
system has a very low tonic activity in basal conditions, and only
when the system is activated pharmacologically or by afferent
stimulation, the antagonist effect becomes obvious (Bowery and
Smart, 2006) as occurs, for example, in chronic pain (Malcangio
and Bowery, 1994). For this reason, blocking GABAB receptors
induces little effects on membrane properties, i.e., membrane
potential or Ri (Lambert et al., 1989; Emri et al., 1996), so GABAB
receptor antagonism would not explain all the effects induced by
Aβ25–35.
Another aspect to consider is that both, GABAB receptors and
GirK channels are coupled and co-expressed in the postsynap-
tic membrane of CA3 pyramidal neurons (Luscher et al., 1997;
Kulik et al., 2003; Lujan et al., 2009) conforming an oligomeric
stable molecular complex (Lujan et al., 2009; Ciruela et al., 2010).
Therefore, Aβ25–35 action on the membrane should include the
effector coupled to GABAB receptor. GirK channels exhibit a
tonic basal activity, even without receptor signaling, due to their
direct binding to the Gα subunit of G proteins (Lujan et al.,
2009). Hence, administration of GirK channel selective antag-
onist (tertiapin-Q) simulates all the effects of Aβ25–35 on the
postsynaptic membrane, i.e., late IPSP reduction, Ri increase
and membrane depolarization, even in the presence of GirK and
GABAB agonists. Furthermore, Aβ25–35 was found to be unable
to generate an additional significant increase in Ri after phar-
macological blocking of GirK channels. These results not only
suggest that GirK channels are functional in the basal state, but
also that Aβ25–35 action seems to be more evident when these
GirK channels are activated.
GirK channels activity alteration may have multiple
implications for synaptic activity and neuronal network function.
Numerous studies have emphasized its role in several patho-
logical processes in the nervous system such as epilepsy, pain,
addiction, Parkinson or Down syndrome (Luscher and Slesinger,
2010). Deletion studies of GirK channels have revealed their role
in learning andmemory processes. GIRK4 knock-outmice exhib-
ited impaired performance in spatial learning and memory test
(Wickman et al., 2000). Moreover, mutations in GIRK2 subunit
reduced LTP and increased LTD in hippocampus (Sago et al.,
1998; Siarey et al., 1999; Luscher and Slesinger, 2010) and it is
especially relevant in Down syndrome, where cerebral Aβ accu-
mulation is greatly accelerated and leads to invariant early-onset
AD neuropathology (Lott and Head, 2005; Moncaster et al., 2010;
Cooper et al., 2012).
The present study proposes a putative synaptic mechanism
for neural network hyperactivity, which is considered as an early
event in AD pathogenesis and is associated with early Aβ depo-
sition in non-demented humans with or without mild cogni-
tive impairment (Sperling et al., 2009). An alteration in GirK
channel conductance of pyramidal CA3 neurons might under-
lie this hyperactivity and the impaired inhibition which has been
related to network dysfunction and alteration of rhythm gener-
ation required for information processing and memory storage
in the septohippocampal system (Palop et al., 2007; Palop and
Mucke, 2010; Villette et al., 2010, 2012; Rubio et al., 2012; Verret
et al., 2012). Our data could be in accordance to the notion that
reducing network hyperactivity would have beneficial effects on
cognitive functions (Palop and Mucke, 2010; Verret et al., 2012).
Subsequently, the present work shows GirK channel as a new
target to study Aβ pathophysiology in early and mild cognitive
impairment in AD. Since cholinergic or glutamatergic treatments
in AD have shown limited success, therapies combining modu-
lators of different neurotransmission systems seem to be a more
promising tool for the treatment, and overall prevention, of this
dementia.
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